Foundersuite: a better way to raise capital

Investor info

Sweet spot

$17,150,000

Stage focus

Seed Round,
Early stage VC,
Later stage VC,
Other

Industry focus

Description

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.

Relevant investments

Company
Amount
Round

Example example company Inc
$ 1,000,000
Investor meetings
Company & Company
€ 11,000,000
Series C funding
Example
$ 524,000
Seed round A

Connected people

Email visible after logging in

Example Exampleexample[email protected]
Example Exampleexample
Notexample Examplenotexample example[email protected]
Example Examplenotexampleexample example[email protected]
Example Exampleexample[email protected]
Example Exampleexample[email protected]

X Feed

Click here to see tweets by Biogen Idec

See other investors focused on

Biotechnology